U.S. Food and Drug Administration (FDA)

FDA Accelerates Cures, Cracks Down on Recalls, and Rewrites the Rules of Review

WASHINGTON, D.C. — The Food and Drug Administration moved aggressively in mid-December to speed promising drug reviews, loosen long-standing evidence barriers, strengthen food recall enforcement, and court private-sector innovation, signaling …

FDA Accelerates Cures, Cracks Down on Recalls, and Rewrites the Rules of Review Read More